Market revenue in 2023 | USD 43.6 million |
Market revenue in 2030 | USD 69.6 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 36.47% in 2024. Horizon Databook has segmented the Kuwait biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait is one of the fastest-growing countries due to its increasing exports and growing economy. With major advancements in its healthcare infrastructure, the country is tackling the growing prevalence of infectious, chronic, and lifestyle-associated diseases. Therefore, the rising prevalence of target diseases in the country is a major factor driving the market.
Furthermore, being a world leader in oil production, the country often faces the challenge of various genetic & rare disorders and the local government is taking enough efforts to tackle the threat of rare diseases by promoting diagnosis rates and facilitating treatment rates. In March 2019, the Center for Arab Genomic Studies participated in the 7th Kuwait international genetic conference.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait biochip market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account